Cellular and molecular basis of remodeling in valvular heart diseases.
Borer
Jeffrey S
JS
The Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College of Cornell University, New York, NY 10021, USA. canadad45@aol.com
Herrold
Edmund McM
EM
Carter
John N
JN
Catanzaro
Daniel F
DF
Supino
Phyllis G
PG
D003971:Diastole; D005109:Extracellular Matrix / Q000473:pathology; D005347:Fibroblasts / Q000473:pathology; D006349:Heart Valve Diseases / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D032383:Myocytes, Cardiac / Q000473:pathology; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use; D020257:Ventricular Remodeling / Q000187:drug effects
D014665:Vasodilator Agents